CDK4 and cancer: CP-10 was tested in several cancer cell lines, including leukaemia (THP-1, HL-60), MCL (Mino, JeKo-1), and MM (MM.1S, RPMI8226), showing differential responses suggesting cell context specificity and differential dependence on CDK4/6.